NASDAQ: MDGL       Madrigal Pharmaceuticals Inc
Last Price Today's Change   Day's Range   Trading Volume
305.595   +5.435 (1.81%)  296.51 - 309.899  131,997


Avg Volume (4 weeks):801,878
4 Weeks Range:107.00 - 325.98
4 Weeks Price Volatility (%):
52 Weeks Range:13.10 - 325.98
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed ß-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. In addition, MGL-3196 also reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action. Geographically, all the business activity is functioned through the US.

  Be the first to like this.


4593  2945  367  647 

Top 10 Active Counters
 AMD 17.12+0.78 
 EEM 44.65-0.58 
 T 32.175-0.975 
 GXP 31.990.00 
 WR 54.000.00 
 GE 13.175-0.125 
 JD 43.74+0.15 
 BAC 29.43+0.15 
 SPY 276.20-0.93 
 IQ 43.075+2.915 
Partners & Brokers